Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Oncol.

Sec. Gynecological Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1613500

This article is part of the Research TopicEmerging Trends in Cancer Research: Diagnostic and Therapeutic BreakthroughsView all 10 articles

Metastatic squamous cell carcinoma with unknown primary site: a case report and brief literature review

Provisionally accepted
YING  YANGYING YANGWei  SunWei SunJun  JiaJun JiaJing  YuJing YuZhiwei  SunZhiwei SunFeng  DuFeng DuYouwu  ShiYouwu ShiJing  SunJing SunSonglin  GaoSonglin GaoYanjie  XiaoYanjie XiaoXiaodong  ZhangXiaodong Zhang*
  • Beijing Cancer Hospital, Peking University, Beijing, China

The final, formatted version of the article will be published soon.

Carcinoma of unknown primary (CUP) is a rare malignancy characterized by metastatic disease without an identifiable primary tumor, even after extensive diagnostic evaluations. This case report described a 70-year-old female patient with squamous cell CUP (SCCUP), who initially presented with elevated Carbohydrate Antigen 19-9 and a diaphragmatic mass. Despite comprehensive workup, including 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography and a 90-gene expression assay, the primary site remained elusive. The patient underwent surgical resection followed by two cycles of systematic therapy, and had achieved the disease-free survival of 14 months. This case underscores the limitations of current diagnostic tools and the potential role of multimodal therapy in CUP management. The discordance between molecular testing and clinical 2 findings further emphasizes the perplexing nature of CUP. The report also reviews literature on diagnosis and therapeutic options. Due to the absence of standardized regimens, future international collaboration and comprehensive genomic profiling are warranted to advance understanding of this heterogeneous disease.

Keywords: Carcinoma of unknown primary, Squamous cell carcinoma, multimodal therapy, comprehensive workup, molecular testing

Received: 17 Apr 2025; Accepted: 30 Sep 2025.

Copyright: © 2025 YANG, Sun, Jia, Yu, Sun, Du, Shi, Sun, Gao, Xiao and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiaodong Zhang, vip2tg@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.